ABBOTT DIAGNOSTICS TECHNOLOGIES AS: årsregnskap 2025 vs 2024
Shrank 13% on revenue, weaker earnings
approved 2026-06-29; registry 2026-07-23; journal 2026 620661
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for ABBOTT DIAGNOSTICS TECHNOLOGIES AS. Revenue 1.99bn NOK → 1.73bn NOK (-12.7%). Net result +382.42m NOK → +118.85m NOK. Equity 11.82bn NOK → 644.16m NOK.
On the constructive side: cash rose. Pressures included: revenue fell; operating result weakened; net result weakened.
Also worth watching: book investments changed. All figures are taken from the published annual accounts for ABBOTT DIAGNOSTICS TECHNOLOGIES AS.
At a glance
Scorecard
What improved
-
↑
Cash rose
Bank deposits 10.15m NOK → 12.06m NOK (+18.9% YoY). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 1.99bn NOK to 1.73bn NOK (-12.7% YoY). Calculated
-
↓
Operating result weakened
Operating result +435.38m NOK → +144.69m NOK (op. margin 21.9% → 8.3%). Calculated
-
↓
Net result weakened
Net result +382.42m NOK → +118.85m NOK (net margin 19.3% → 6.9%). Calculated
-
↓
Equity eroded
Book equity 11.82bn NOK → 644.16m NOK (equity ratio 871.0% → 50.3%). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 1.08× → 1.00× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 507.55m NOK → 313.38m NOK. Reported fact